3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
15
Phase 2
6
Phase 1/2
2
Phase 4
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Conditions
Polycythemia Vera
1
Interventions
nilotinib
12
Imatinib Mesylate
11
Dasatinib
3
ruxolitinib
2
posaconazole
2
fludarabine
2
bosutinib
2
asciminib
2
Cyclophosphamide
2
Busulfan
2
zanubrutinib
1
trametinib
1
pegaspargase
1
flumatinib
1
fludarabine phosphate
1
eltrombopag
1
dabrafenib
1
avapritinib
1
Thiotepa
1
Rituximab
1
Radiotherapy
1
Phlebotomy
1
Peripheral Blood Stem Cell Transplantation
1
Panobinostat
1
Micafungin
1
Interferons
1
Idarubicin
1
Hydroxyurea
1
Growth Hormone
1
Granulocyte Colony-Stimulating Factor
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Hydroxyurea
×
Myeloid
×
Clear all
NCT05853458
2026-04-30
HU-F-AIM
Novartis
Phase 4
Terminated
76 enrolled